January 23, 2004 - Volume 18 - Issue 2 - Contributor Index

Author:
Cabrero, Esther

Virological phenotype switches under salvage therapy with lopinavir–ritonavir in heavily pretreated HIV-1 vertically infected children

Galán, Isabel; Jiménez, José L; González-Rivera, Milagros; More

AIDS . 18(2):247-255, January 23, 2004.

Author:
Calvez, Vincent

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS . 18(2):217-226, January 23, 2004.

Author:
Canestri, Ana
Author:
Casabona, Jordi
Author:
Cejtin, Helen
Author:
Charlett, Andre

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS . 18(2):227-235, January 23, 2004.

Author:
Chohan, Bhavna

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS . 18(2):295-301, January 23, 2004.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

Vanichseni, Suphak; Tappero, Jordan W; Pitisuttithum, Punnee; More

AIDS . 18(2):311-316, January 23, 2004.

Author:
Clerici, Mario
Author:
Corzo, Juan E

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS . 18(2):217-226, January 23, 2004.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS . 18(2):227-235, January 23, 2004.